BiotechTube
Home/BOOST Pharma/Elaine Jones
EJ

Elaine Jones

Board Chair

BOOST Pharma

Therapeutic Areas

Rare DiseaseGenetic DisordersOrthopedics

BOOST Pharma Pipeline

DrugIndicationPhase
BT-101 (BOOST Cells)Osteogenesis Imperfecta (moderate to severe, pediatric)Phase 3 Preparations

Leadership Team at BOOST Pharma

HS
Hans Schambye
Chief Executive Officer
DC
Dr. Cecilia Götherström
Chief Scientific Officer, Co-founder
LH
Louise Himmelstrup
Chief Regulatory Officer
View full BOOST Pharma profile